We have also learnt that there is a third subtype of cutaneous disease called NRAS/BRAF wild‐type melanoma, which is characterized by a high C > T mutation burden, amplifications and mutation of c‐KIT, and alterations of NF128, 30. Here, BRAF is linked to melanoma.